BEVERLY JCG LTD. (9QX) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of BEVERLY JCG LTD. stock S$0.00, price S$0.00, that is 10.0% below the price, quality 47 out of 100. Rating: overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
BEVERLY JCG LTD.
9QX · SGExpensive (fair value 10% below the price) and falling price, but company just good enough: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 0.0030 SGD – 0.1000 SGD · the 0.0030 SGD price screens above the 0.0027 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether BEVERLY JCG is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Beverly Wilshire Ltd., an investment holding company, engages in the trading and distribution, and medical businesses in Singapore and Malaysia. The company operates through three segments: Trading and Distribution; Aesthetic Medical and Healthcare; and Investment and Others.
Show moreShow less
The Trading and Distribution segment engages in the trading and distribution of steel raw materials, consumables, instruments, and semi-finished products for steel mills, iron and steel foundries, and aluminum smelters in the Asia-Pacific region, as well as provision of ancillary services.
The Aesthetic Medical segment offers aesthetic medical services, including the provision of aesthetic medical, beauty, and wellness services. The Investment and Others segment provides management services, as well as marketing, distribution, and related services.
The company provides plastic surgery, cosmetic and reconstructive surgery, aesthetic dental care, cosmetological and aesthetical related treatments, hair transplant, physiotherapy, spa, and reflexology services; healthy aging therapy, health screening and wellness, and medical research services; and operates medical specialist center with outpatient and day care services and activities.
It also offers clinical and other general medical services, and beauty salons. The company was formerly known as Beverly JCG Ltd. and changed its name to Beverly Wilshire Ltd. in September 2025. Beverly Wilshire Ltd. was founded in 1987 and is headquartered in Singapore.
Stock analysis
BEVERLY JCG LTD. (9QX) currently trades at 0.0030 SGD, while our model-based Fair Value estimate is 0.0027 SGD, 10% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 80/100, which puts the data coverage at low.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
BEVERLY JCG LTD. reported revenue of 9.4M SGD in FY2025 versus 9.0M SGD in FY2021, a compound +1.2%/yr. Reported net income was 46.0K SGD in FY2025.
Key figures
Market cap 3.6M SGD (≈ $2.8M) Micro · P/S ratio 0.60 · Net margin 0.5% · Return on equity −198% · Return on assets (EBIT) −41.1% (5-year average) · Operating margin −7.3% · Revenue (TTM) 8.0M SGD · Revenue growth (YoY) −28.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 75% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at −10%, 9QX screens richer than that median.
Fair Value models
All 1 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
9QX screens overvalued: fair value 10% below the price. Compare with HCA Healthcare, Inc →
Compare BEVERLY JCG LTD. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- PEG screener for stocks with fair value
- Valuation of the Singapore market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $22.03 | $45.73 | +108% | vs 9QX |
| DaVita Inc DVA | $174.56 | $218.90 | +25% | vs 9QX |
| Aier Eye Hospital Group 300015 | ¥8.99 | ¥10.88 | +21% | vs 9QX |
| HCA Healthcare, Inc HCA | $499.05 | $547.34 | +10% | vs 9QX |
| Tenet Healthcare Corporation THC | $286.03 | $279.20 | −2% | vs 9QX |
| The Ensign Group ENSG | $188.41 | $140.09 | −26% | vs 9QX |
| Encompass Health Corporation EHC | $140.99 | $94.81 | −33% | vs 9QX |
| Fresenius SE FRE | €53.86 | €34.77 | −35% | vs 9QX |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,771 | ₹5,234 | −40% | vs 9QX |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 211.40 SAR | 109.45 SAR | −48% | vs 9QX |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is BEVERLY JCG LTD. (9QX) overvalued or undervalued?
What is the fair value of 9QX?
What is the quality score of 9QX?
What is the price target for BEVERLY JCG LTD. (9QX)?
What is the BEVERLY JCG LTD. stock forecast for 2026?
What is the revenue of BEVERLY JCG LTD. (9QX)?
What is the intrinsic value of BEVERLY JCG LTD. (9QX)?
Is BEVERLY JCG LTD. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 9QX?
How much is BEVERLY JCG LTD. worth?
How solid is the balance sheet of BEVERLY JCG LTD. (9QX)?
How far is 9QX from its 52-week high?
Which stocks are comparable to BEVERLY JCG LTD.?
Is BEVERLY JCG LTD. stock attractive at the current price?
How is the fair value of 9QX calculated?
Is it still worth investing in stocks now?
What is the share price of BEVERLY JCG LTD. (9QX)?
What should I pay attention to with BEVERLY JCG LTD. right now?
Key figures of BEVERLY JCG LTD.
How large is the market capitalisation of BEVERLY JCG LTD. (9QX)?
What is the P/S ratio of BEVERLY JCG LTD. (9QX)?
What is the net margin of BEVERLY JCG LTD. (9QX)?
What is the return on equity of BEVERLY JCG LTD. (9QX)?
What is the EBIT return on assets of BEVERLY JCG LTD. (9QX)?
What is the operating margin of BEVERLY JCG LTD. (9QX)?
How fast is revenue growing at BEVERLY JCG LTD. (9QX)?
How much free cash flow does BEVERLY JCG LTD. (9QX) generate?
How much net debt does BEVERLY JCG LTD. (9QX) carry?
Watch BEVERLY JCG LTD. in the live analysis
One click puts BEVERLY JCG LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.